Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
RNXT
RNXT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest RNXT ETF News Today | Earnings, Events & Price Alerts
RNXT News
RenovoRx Expands RenovoCath Adoption Across U.S. Cancer Centers
4d ago
Yahoo Finance
RenovoRx Expands Market for Cancer Treatment Device
5d ago
Newsfilter
RenovoRx Clinical Data Abstract Accepted for Presentation at SIR 2026
6d ago
Newsfilter
Wall Street Analysts Adjust Ratings
Feb 17 2026
Benzinga
RenovoRx Forms Medical Advisory Board to Enhance Oncology Strategies
Feb 10 2026
Newsfilter
RenovoRx Announces New Clinical Data Presentation
Feb 04 2026
Newsfilter
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
PRnewswire
Oncolytics Biotech's Breakthroughs in Cancer Treatment
Jan 30 2026
Newsfilter
RenovoRx to Present New Research at 2026 SIO Meeting
Jan 28 2026
Newsfilter
Bark Inc (BARK) Shares Surge 19.9% on Acquisition Proposal from Great Dane
Jan 12 2026
Benzinga
Oncolytics Biotech Fortifies IP Protection, Extends Pelareorep Commercial Runway to 2044
Jan 08 2026
Globenewswire
AZZ Inc Reports Q3 Earnings Beat, Shares Rise 2.1%
Jan 08 2026
Benzinga
ALX Oncology Gains 10.17% on Positive Phase 2 Trial Data for Evorpacept
Jan 08 2026
NASDAQ.COM
Novo Nordisk (NVO) Gains 9.48% After FDA Approves Wegovy Obesity Pill
Dec 23 2025
NASDAQ.COM
After-Hours Gains on Friday: Biotech and Genomics Stocks Demonstrate Resilience
Dec 22 2025
NASDAQ.COM
Repare Surges 30%, Nuvalent Rises 9% in After-Hours Biotech Gains
Nov 17 2025
NASDAQ.COM
Show More News
